Log In
BCIQ
Print this Print this
 

levodopa/carbidopa (ND0612H)

  Manage Alerts
Collapse Summary General Information
Company NeuroDerm Ltd.
DescriptionHigh-dose formulation of liquid levodopa and carbidopa delivered via a continuous, subcutaneous belt pump
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat advanced Parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today